Antithrombotic therapy after TAVI: Better alone than with a bad company
Sign Up to like & getrecommendations! Published in 2023 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30589
Abstract: Among patients who benefited from a successful transcatheter aortic valve implantation (TAVI) and without indication for chronic oral anticoagulation (OAC), the use of temporary dual antiplatelet therapy (DAPT) followed by single antiplatelet therapy (SAPT) long‐life… read more here.
Keywords: tavi; therapy; mortality; risk ... See more keywords
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial
Sign Up to like & getrecommendations! Published in 2022 at "Open Heart"
DOI: 10.1136/openhrt-2021-001892
Abstract: Objective Managing antithrombotic therapy in patients with atrial fibrillation (AF) and an acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI) is challenging and can be affected by prior oral anticoagulant (OAC) treatment. We examined… read more here.
Keywords: prior oac; prior oral; trial; oral anticoagulant ... See more keywords
Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation
Sign Up to like & getrecommendations! Published in 2022 at "Neurology"
DOI: 10.1212/wnl.0000000000206748
Abstract: Background and Objectives Nonvalvular atrial fibrillation (NVAF) is associated with an increased risk of dementia. Oral anticoagulants (OACs) are essential for stroke prevention in NVAF, and studies have shown a possible protective effect on dementia.… read more here.
Keywords: oac use; risk dementia; decreased risk; dementia ... See more keywords
Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2022.28.12.1400
Abstract: BACKGROUND: Oral anticoagulants (OAC) is indicated for stroke prevention in patients with atrial fibrillation (AF) with a moderate or high risk of stroke. Despite the benefits of stroke prevention, only 50%-60% of Americans with nonvalvular… read more here.
Keywords: patients atrial; claims data; underprescribing underfilling; oac use ... See more keywords
Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2022.28.2.266
Abstract: BACKGROUND: For atrial fibrillation (AF) patients, oral anticoagulants (OACs) can reduce the risk of stroke by 60%; however, nearly 50% of patients recommended to receive OACs do not receive therapy. Integrated insurers that cover pharmacy… read more here.
Keywords: oac use; adherence; use; prescription drug ... See more keywords